NCT05021588View on ClinicalTrials.gov

Steroid and Anticoagulant Therapy in covid19

NACompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

April 12, 2020

Primary Completion Date

August 2, 2020

Study Completion Date

September 10, 2020

Conditions
Pneumonia, Viral
Interventions
PROCEDURE

steroid and anticoagulants according to different protocols.

As no standard treatment for COVID-19 was approved; there are many treatment protocols for anti-inflammatory corticosteroids and anti-coagulantsfor severe COVID-19 pneumonia cases, this study aims to assess the most suitable modality in this high-risk group.

Trial Locations (1)

11711

Marwarady, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT05021588 - Steroid and Anticoagulant Therapy in covid19 | Biotech Hunter | Biotech Hunter